New Strategy for Receptor-Based Pharmacophore Query Construction: A Case Study for 5-HT7 Receptor Ligands

In this paper, a new approach for generating receptor-based 3D pharmacophore models for rapid in silico virtual screening is presented. The method combines information from docking poses of known ligands of different structures and further ligand-receptor complexes analyses using structural interaction fingerprints (SIFts). Next, the best linear combination of three-, four-, and five-feature pharmacophores in terms of selected performance parameter (i.e., recall, F-score, and MCC) is constructed. The resultant queries showed significantly better VS performance and new scaffold recognition when compared with the known ligand- and receptor-based pharmacophore models. The approach was developed and validated on 5-HT₇ receptor homology models created on available crystal structure templates. The efficiency of the obtained linear combinations exhibited only a minor dependence on the template selection.

[1]  T. Blundell,et al.  Comparative protein modelling by satisfaction of spatial restraints. , 1993, Journal of molecular biology.

[2]  Thierry Langer,et al.  LigandScout: 3-D Pharmacophores Derived from Protein-Bound Ligands and Their Use as Virtual Screening Filters , 2005, J. Chem. Inf. Model..

[3]  Andreas Evers,et al.  Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening. , 2009, Journal of medicinal chemistry.

[4]  Chris de Graaf,et al.  Snooker: A Structure-Based Pharmacophore Generation Tool Applied to Class A GPCRs , 2011, J. Chem. Inf. Model..

[5]  L. Pardo,et al.  Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives. , 2003, Journal of medicinal chemistry.

[6]  Thierry Langer,et al.  The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening. , 2006, Journal of medicinal chemistry.

[7]  Andrzej J Bojarski,et al.  Pharmacophore models for metabotropic 5-HT receptor ligands. , 2006, Current topics in medicinal chemistry.

[8]  P. Goodford.  A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[9]  John P. Overington,et al.  ChEMBL: a large-scale bioactivity database for drug discovery , 2011, Nucleic Acids Res..

[10]  Stefano Alcaro,et al.  GBPM: GRID-based pharmacophore model: concept and application studies to protein-protein recognition , 2006, Bioinform..

[11]  K. Dill,et al.  A fast conformational search strategy for finding low energy structures of model proteins , 1996, Protein science : a publication of the Protein Society.

[12]  Luhua Lai,et al.  LigBuilder: A Multi-Purpose Program for Structure-Based Drug Design , 2000 .

[13]  Ingebrigt Sylte,et al.  Protein binding site analysis by means of structural interaction fingerprint patterns. , 2011, Bioorganic & medicinal chemistry letters.

[14]  J. Irwin,et al.  Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.

[15]  Z. Deng,et al.  Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. , 2004, Journal of medicinal chemistry.

[16]  Malcolm J. McGregor,et al.  Pharmacophore Fingerprinting. 1. Application to QSAR and Focused Library Design , 1999, J. Chem. Inf. Comput. Sci..

[17]  J. Lavandera,et al.  First pharmacophoric hypothesis for 5-HT7 antagonism. , 2000, Bioorganic & medicinal chemistry letters.

[18]  J. Irwin,et al.  ZINC ? A Free Database of Commercially Available Compounds for Virtual Screening. , 2005 .

[19]  R. Griffith,et al.  Pharmacophore design and database searching for selective monoamine neurotransmitter transporter ligands. , 2008, Journal of molecular graphics & modelling.

[20]  Malcolm J. McGregor,et al.  Pharmacophore Fingerprinting. 2. Application to Primary Library Design , 2000, J. Chem. Inf. Comput. Sci..

[21]  Mark Goadrich,et al.  The relationship between Precision-Recall and ROC curves , 2006, ICML.

[22]  Gilles Marcou,et al.  Hot-Spots-Guided Receptor-Based Pharmacophores (HS-Pharm): A Knowledge-Based Approach to Identify Ligand-Anchoring Atoms in Protein Cavities and Prioritize Structure-Based Pharmacophores , 2008, J. Chem. Inf. Model..

[23]  J. Silberg,et al.  A transposase strategy for creating libraries of circularly permuted proteins , 2012, Nucleic acids research.

[24]  B. Matthews.  Comparison of the predicted and observed secondary structure of T4 phage lysozyme. , 1975, Biochimica et biophysica acta.

[25]  Mateusz Nowak,et al.  Receptor-based pharmacophores for serotonin 5-HT7R antagonists-implications to selectivity. , 2006, Journal of medicinal chemistry.

[26]  Didier Rognan,et al.  Protein-Ligand-Based Pharmacophores: Generation and Utility Assessment in Computational Ligand Profiling , 2012, J. Chem. Inf. Model..

[27]  Woody Sherman,et al.  Novel Method for Generating Structure-Based Pharmacophores Using Energetic Analysis , 2009, J. Chem. Inf. Model..

[28]  D T Jones,et al.  Protein secondary structure prediction based on position-specific scoring matrices. , 1999, Journal of molecular biology.

[29]  Amos Bairoch,et al.  PROSITE: A Documented Database Using Patterns and Profiles as Motif Descriptors , 2002, Briefings Bioinform..

[30]  Arne Elofsson,et al.  PONGO: a web server for multiple predictions of all-alpha transmembrane proteins , 2006, Nucleic Acids Res..

[31]  Anton J. Hopfinger,et al.  Application of Genetic Function Approximation to Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..

[32]  Jing Chen,et al.  Pocket v.2: Further Developments on Receptor-Based Pharmacophore Modeling , 2006, J. Chem. Inf. Model..